DexCom Infringes Abbott Patent in Mixed Verdict on CGM Tech (2)

DexCom Inc.'s G6 continuous glucose monitors infringe one of three patents held by an Abbott Laboratories subsidiary, but a federal jury in Delaware couldn’t reach a verdict on infringement of a fourth patent related to the devices, which track blood-sugar levels without fingersticks.

Jurors didn’t address damages in the verdict, issued March 22 in the US District Court for the District of Delaware.

The verdict marks the latest development in a sprawling dispute whose roots date back nearly 20 years, with clashes in domestic venues ranging from federal district and appeals courts to an administrative tribunal, along with foreign ...